Biochemical Markers of Bone Turnover.
- Author:
Deog Yoon KIM
- Publication Type:Original Article
- Keywords:
Biochemical marker;
Bone turnover;
Osteoporosis
- MeSH:
Aged;
Alkaline Phosphatase;
Biomarkers*;
Calcitonin;
Circadian Rhythm;
Diet;
Diphosphonates;
Estrogens;
Female;
Hip;
Humans;
Kinetics;
Osteocalcin;
Osteoporosis;
Treatment Outcome
- From:Korean Journal of Nuclear Medicine
1999;33(4):341-351
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Biochemical markers of bone turnover has received increasing attention over the past few years, because of the need for sensitive and specific tool in the clinical investigation of osteoporosis. Bone markers should be unique to bone, reflect changes of bone loss, and should be correlated with radiocalcium kinetics, histomorphometry, or changes in bone mass. The markers also should be useful in monitoring treatment efficacy. Although no bone marker has been established to meet all these criteria, currently osteocalcin and pyridinium crosslinks are the most efficient markers to assess the level of bone turnover in the menopausal and senile osteoporosis. Recently, N-terminal telopeptide (NTX), C-terminal telopeptide (CTX) and bone specific alkaline phosphatase are considered as new valid markers of bone turnover. Recent data suggest that CTX and free deoxypyridinoline could predict the subsequent risk of hip fracture of elderly women. Treatment of postmenopausal women with estrogen, calcitonin and bisphosphonates demonstrated rapid decrease of the levels of bone markers that correlated with the long-term increase of bone mass. Factors such as circadian rhythms, diet, age, sex, bone mass and renal function affect the RESULTS of biochemical markers and should be appropriately adjusted whenever possible. Each biochemical markers of bone turnover may have its own specific advantages and limitations. Recent advances in research will provide more sensitive and specific assays.
